Videos

William Schaffner, MD, explains the strengths and weaknesses of the flu vaccine.

Daniel Diekema, MD, describes recent developments made in rapid and molecular diagnostic testing in the microbiology lab, and how these tests strengthen infection prevention efforts.

Dr. Richard Vickers explains how recurrent infection is an unmet medical need when it comes to C. difficile.

Richard Haupt, MD, MPH, discusses the different pharmaceutical companies’ efforts to develop a C. difficile vaccine.

Michael Edmond, MD, MPH, MPA, explains who is in charge of leading infection control programs in hospitals.

Pedro Cahn, MD, shares the results found after 96-weeks of follow-up for the onceMRK Phase 3 clinical trial.

William Schaffner, MD, shares stories to motivate patients and health care providers to receive the flu vaccine.

Jake Glaser describes how recent advances against HIV & AIDS have affected the philanthropic community.

Richard Haupt, MD, MPH, explains how Pfizer is addressing the need for a C. difficile vaccine.

Robert Bransfield, MD, DLFAPA, discusses direct methods that can be used to acquire statistics related to suicides that are a result of Lyme and associated diseases.

Edmond Hooker, MD, DrPH, discusses how many people have fallen ill or even died due to contaminated hospital mattresses.

Jake Glaser explains the challenges faced when fundraising for AIDS programs in the 21st century.

Dr. Richard Vickers explains how antibiotics to treat Clostridium difficile infection cause collateral damage to the gut microbiome.

William Schaffner, MD, addresses common misconceptions regarding the influenza vaccine.

Michael Edmond, MD, MPH, MPA, explains how strategies are developed to address different threats in health care settings.

Edmond Hooker, MD, DrPH, discusses the reasons behind why hospital rooms are not being disinfected properly.

Jake Glaser shares who he feels is going to end the AIDS epidemic.

Jake Glaser shares what is needed to achieve the Fast-Track strategy to end the AIDS epidemic by 2030.

Richard Haupt, MD, MPH, explains how a vaccine can serve as a primary prevention modality against C. difficile.

Daniel Diekema, MD, discusses the different roles that clinical laboratories play in outbreak response.

William Schaffner, MD, offers insight into the 2017-2018 flu season, including which strain of the virus that is expected to be most prevalent.

Leonard Sigal, MD, discusses different causes of persisting symptoms after Lyme disease infection.

Richard Haupt, MD, MPH, explains why a vaccine to help prevent C. difficile is so needed.

Michael Edmond, MD, MPH, MPA, explains how health care facilities can work on preparing for the unexpected in the realm of infectious diseases.

Edmond Hooker, MD, DrPH, explains why hospital mattresses are harder to disinfect than other harder surfaces.

Daniel Diekema, MD, explains why microbiology labs should be seen as an integral part of antimicrobial stewardship efforts.

James S. Lewis, PharmD, FIDSA, discusses the role vaccination plays in reducing unnecessary antibiotic use.

William Schaffner, MD, lists some of the common reasons behind why individuals decide against getting their flu shots, and why they should reconsider.

Robert Bransfield, MD, DLFAPA, explains how he was able to establish a correlation between suicidal risk and Lyme disease.

Richard Haupt, MD, MPH, explains the risk factors for Clostridium difficile infection.